Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients. (Record no. 16121627)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01831 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515015821.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200606s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0302-282X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1159/000091724 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Mühlbacher, M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20060601 |
| 245 00 - TITLE STATEMENT | |
| Title | Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Neuropsychobiology |
| Date of publication, distribution, etc. | 2006 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 83-7 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antidepressive Agents, Tricyclic |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Depressive Disorder, Major |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fatigue |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Headache |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Injections, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Inpatients |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mianserin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mirtazapine |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nausea |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Psychiatric Status Rating Scales |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Statistics, Nonparametric |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vertigo |
| General subdivision | chemically induced |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Konstantinidis, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kasper, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eichberger, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hinterhuber, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hofmann, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nimmerrichter, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schubert, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Egger, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nickel, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stuppaeck, C |
| 773 0# - HOST ITEM ENTRY | |
| Title | Neuropsychobiology |
| Related parts | vol. 53 |
| -- | no. 2 |
| -- | p. 83-7 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1159/000091724">https://doi.org/10.1159/000091724</a> |
| Public note | Available from publisher's website |
No items available.